Clinical Trial: De Novo Gastroesophageal Reflux Disease After Sleeve Gastrectomy With and Without Omentopexy

U.S., Oct. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07854613) titled 'De Novo Gastroesophageal Reflux Disease After Sleeve Gastrectomy With and Without Omentopexy' on Sept. 27.

Brief Summary: The goal of this clinical trial is to compare the effects of sleeve gastrectomy with and without omentopexy on gastroesophageal reflux disease (GERD) in patients with obesity. The main question it aims to answer is:

Does the addition of omentopexy to sleeve gastrectomy reduce the incidence of postoperative GERD compared with sleeve gastrectomy alone, as measured by the proportion of participants with a postoperative GERD-Q score >=8?

Researchers will compare sleeve gastrectomy with omentopexy to sleeve gastrecto...